BVCF
Venture capitalShanghai · Series A–Late Stage · 18 people tracked
Investment thesis
BVCF concentrates on the Chinese life sciences sector, aiming to create and grow innovative companies with global reach. Since its founding in 2005, the firm has sought to advance health outcomes while generating returns, positioning itself at the intersection of Chinese and global life sciences markets. It has drawn global institutional financial and strategic investors to support this mission.
Source: firm website, verified Aug 25, 2026.
Team · 18 people
from the firm's website & curated & public directories
Frequently asked questions
- What stage does BVCF invest at?
- BVCF invests at the Series A, Series B, Late Stage stages.
- What is BVCF's typical check size?
- BVCF typically writes checks of $5M.
- What sectors does BVCF focus on?
- BVCF focuses on Biotech, Healthtech, Medical Devices.
- Where is BVCF located?
- BVCF is headquartered in Shanghai, CN.
Media · Podcasts & interviews
featuring the teamFive Questions For BVCF's Founder Dr. Zhi Yang
China Money Network · Zhi Yang
Co-investors · 2
Earlybird Venture Capital is a European venture capital investor that backs early-stage technology founders with capital, strategic support, and access to an international network.
Pivotal Life Sciences is an investment platform focused on funding innovative companies developing therapeutic products and technologies aimed at major unmet medical needs.
Firms observed investing alongside BVCF, from public investor directories. Shared companies are the overlap with BVCF's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Mohr Davidow Ventures is a venture capital firm that backs entrepreneurs pursuing large market opportunities and capable of attracting top-tier talent.
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.